|
|
| APPA's room block at the Sandestin Golf and Beach Resort has been extended until March 14, but we encourage you to go ahead and book your room!
See details below.
| |
| We e-mailed you earlier this week to determine if there were enough interest in adding a practice managers mini-conference on Saturday, March 6. Based on your response we are moving forward with this!
An agenda will be available soon. Encourage your practice mangers to register using the links below.
| |
| Conference Spotlight: When the Joy of Practicing Medicine Turns Against You: Dealing with Compassion Fatigue in the Physician and Caretakers
Tarak Vasavada, MD, DFAPA
| |
Tarak Vasavada, MD, PhD, is medical director of Behavior Health Services at Huntsville Hospital, and serves as regional director of AAPI SE central region. He is a former professor and regional chair of psychiatry at UAB Hunstville Campus. He is a past president of Alabama Psychiatric Physicians Association and Alabama Association of Indian Physicians, and is a distinguished fellow of the American Psychiatric Association. He received is medical degree from Baroda Medical College in India, and completed his residency from SUNY Upstate Medical College Syracuse. Dr. Vasavada's areas of interest include medical teaching, psychopharmacology, consultation psychiatry and serious mental illness. He will present When the Joy of Practicing Medicine Turns Against You: Dealing with Compassion Fatigue in the Physician and Caretakers on Saturday, April 6, at 9:30 a.m
| |
| Conference Spotlight: Less is More Redux: Rationale for Extended Dosing
Roger A. Boshes, MD, PhD
| |
Roger A. Boshes, MD, PhD, is an associate professor at the University of Massachusetts Medical School. He also served on the faculty of Brown University Medical School, Harvard Medical School, University of Illinois College of Medicine and University of Pennsylvania School of Medicine. He serves as Medical Director of the John C. Corrigan Outpatient Medication Clinic and Inpatient Unit, in Fall River, MA. Most of Dr. Boshes' career has focussed on treating the economically disadvantaged and chronically mentally ill - specifically patients dealing with schizophrenia. As a teacher, he emphasizes the importance of showing respect to patients in addition to educating them about their mental illness and treatments.
Dr. Boshes will present Less is More Redux: Rationale for Extended Dosing on Saturday, April 6, at 11:00 a.m.
| |
| Accommodations
Sandestin Golf and Beach Resort
| |
 | Sandestin - Village of Baytowne Wharf |
| Sandestin Golf and Beach Resort
9300 Emerald Coast Pkwy W
Miramar Beach, FL 32550
www.sandetin.com
APPA has reserved a block of rooms at the Sandestin Golf & Beach Resort. Room rates begin at $186 per night and apply for three days before and three days after our conference dates based on availability. Call Sandestin Group Reservations at (800) 320-8115 with group code 23M8OR or reserve a room online. Room block closes on March 14, 2019, but rooms are likely to sell out!
| |
Call for Abstracts
In conjunction with the Spring Conference, APPA will host a Resident/Medical Student Poster Contest. Residents and students who are interested in participating are asked to coordinate with a faculty member in preparing a poster for the meeting. The posters are assigned abstract numbers and are published on the APPA website so they count as “Published Abstracts” on your CV. This is a very easy way to build your academic portfolio!
The posters will be judged at the conference and awards given to the highest ranking posters.
Abstracts should be sent to Luke Engeriser, MD, by March 15 for consideration. ( Examples of abstracts)
| |
Look Who's Coming!
Patrick Bruce Atkins, MD, DFAPA, Alabama Department of Mental Health, Tuscaloosa
Laura Baird, LPC, MPA, Montgomery
Roger A. Boshes, MD, PhD, University of Massachusetts Medical School, Fall River, MA
Judith M. Bowen, MD, DFAPA, Drs. Bowen and Kowalski, LLP, Birmingham
William B. Brooks, MD, DFAPA, AltaPointe Health Systems, Mobile
Irena Bukelis, MD, University of Alabama at Birmingham
Krystal Burch, LPC, New Directions Behavioral Health, Birmingham
Mary Cohen-Colson, MD, AltaPointe Health Systems, Mobile
Rachel Davis, MD, CU Anshutz/University of Colorado Denver, Aurora, CO
Jennifer Dwyer, MD, PhD, Yale University, New Haven, CT
J. Luke Engeriser, MD, FAPA, AltaPointe Health Systems, Mobile
Katherin Freeman, MD, University of Alabama - Birmingham
Griffin Gibson, MD, USA Department of Psychiatry, Mobile
J. Ashley Hagemeyer, MD, Private Practice, Birmingham
Tina Jackson, MD, University of South Alabama, Mobile
Martin P. Kafka, MD, Harvard Medical School, Newton, MA
F. Cleveland Kinney, PhD, MD, University of Alabama - Birmingham
Fernando Lopez, MD, SpectraCare, Dothan
Clinton Martin, MD, UAB, Huntsville
Daniel Mejer, MD, Private Practice, Pike Road
Manuel Morales, MD, University of Missouri-Kansas City School of Medicine, Overland Park, KS
Serena Nimityongskul, MD, University of South Alabama, Mobile
Janaki Nimmagadda, MD, University of Alabama - Birmingham, Huntsville
Godehard Oepen, MD, PhD, DFAPA, Grayson & Associates, Birmingham
Sandra Parker, MD, DFAPA, AltaPointe Health Systems, Mobile
Stacy L. Siegel, MD, Private Practice, Birmingham
Lindsey Stewart, MD, USA Department of Psychiatry, Mobile
Nancy Thomas, LPC, New Directions Behavioral Health, Birmingham
Pamela G. Tucker, MD, Agency for Toxic Substances and Disease Registry
Richard H. Weisler, MD, DFAPA, University of North Carolina Chapel Hill School of Medicine; Duke University Medical Center, Raleigh, NC
Amanda Williams, MD, Gardenia Cove, Montgomery
Tarak Vasavada, MD, DFAPA, Huntsville Hospital
Hal Veits, MD, DLFAPA, Private Practice, Mobile
| |
APPA depends on support from vendors to make our conference affordable for attendees. Please share our prospectus with companies who visit your facility and invite them to be an exhibitor. Contact Meghan Martin for details. APPA thanks the following companies for their support of our Spring 2019 Conference! Acadia Pharmaceuticals, Inc.
Alkermes, Inc.
Allergan Pharmaceuticals
Behavioral Health Systems
Johnson & Johnson
Lundbeck
Neurocrine Biosciences, Inc.
NeuroStar
New Directions Behavioral Health
Professional Risk Management Services, Inc.
Sunovion Pharmaceuticals, Inc.
Team Health
Wexford Health Resources
| |
| Did you miss an issue of Conference Notes? Past issues are posted on our website.
| |
| Continuing Medical Education
| |
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Medical Association of the State of Alabama through the joint providership of the Medical Foundation of Alabama and the Alabama Psychiatric Physicians Association. The Medical Foundation of Alabama is accredited by the Medical Association of the State of Alabama to provide continuing medical education for physicians. Designation Statement
The Medical Foundation of Alabama designates this live activity for a maximum of 12 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
| |
| Learning Objectives - Recognize a widening of their conceptual and therapeutic framework regarding trauma and disasters on a large scale. Local rules and programs will be explored.
- Describe at least three different sexual disorders, their differential diagnosis and evidence-based treatments, and re-examine their own stand, concepts, and role in assessing and treating sexual addictions.
- Explain the indications and mechanism of subcortial deep brain stimulation in OCD.
- Identify the therapeutic potential of psychedelic drugs, their risks, and their recent use in research and treatment of mental disorders (MDD, PTSD).
- List the 8 factors of the Bowen Family Systems Therapy, and practical ways to integrate these into their clinical practice.
- Explain the benefits and drawbacks of Intermittent Dosing in Schizophrenia, and how to choose the best treatment options for patients.
- Demonstrate social-contextual and molecular-biological factors in the causation and treatment of MDD in adults and Children & Adolescents, and explain the mechanism of Ketamine treatment.
- Acknowledge the powerful role of art in human life, in patients with mental illness, and their own life; they will be able to explain better assessments of patient’s skills, impairments or new creativity, and helpful ways to use art in treatment.
- Cite the main factors of mindfulness, and be able to instruct their patients how to use mindfulness meditation in different psychiatric conditions.
- Recognize at least 3 early signs of burn-out and compassion fatigue, and name two helpful countermeasures.
| |
|
|
|
|
